Blog
RSS FeedPosted by Michael Wonder on 29 Jul 2020
TGA approves new medicine for basal cell carcinoma
29 July 2020 - Cemiplimab (Libtayo) has been provisionally registered by the TGA. ...
Posted by Michael Wonder on 27 Jul 2020
TGA approves Zeposia for patients with multiple sclerosis
27 July 2020 - Zeposia has been approved under the Black Triangle Scheme. ...
Posted by Michael Wonder on 15 Jul 2020
Deciphera announces Australian Therapeutic Goods Administration’s approval of Qinlock (ripretinib) for the treatment of fourth-line gastro-intestinal stromal tumour
14 July 2020 - Qinlock is the first approved tyrosine kinase inhibitor designed specifically for GIST regardless of patients’ mutational status. ...
Posted by Michael Wonder on 13 Jul 2020
TGA publishes more details on its approval of COVID-19 medicine Veklury
13 July 2020 - Remdesivir granted conditional approval in record time. ...
Posted by Michael Wonder on 11 Jul 2020
Australia's first COVID treatment approved
10 July 2020 - The Therapeutic Goods Administration has granted provisional approval to remdesivir (Veklury, Gilead Sciences) as the first ...
Posted by Michael Wonder on 25 May 2020
TGA approves Rozlytrek
25 May 2020 - Roche secures TGA approval for another cancer medicine. ...
Posted by Michael Wonder on 08 May 2020
Influenza vaccines released for 2020 season
8 May 2020 - Six influenza vaccines are available in Australia in 2020. All of these vaccines are quadrivalent, which ...
Posted by Michael Wonder on 31 Mar 2020
TGA publishes another AusPAR for Opdivo (nivolumab)
31 March 2020 - First apparent TGA rejection for nivolumab. ...
Posted by Michael Wonder on 04 Mar 2020
International work-sharing initiative - baloxavir marboxil (Xofluza)
5 March 2020 - The Therapeutic Goods Administration (TGA) has approved a new medicine for the treatment of influenza (flu) as ...
Posted by Michael Wonder on 04 Mar 2020
Anti-flu pill can fight illness as soon as symptoms show
4 February 2020 - A new pill that can fight the flu as soon as symptoms strike has been approved ...
Posted by Michael Wonder on 21 Nov 2019
FDA takes second action under international collaboration, approves new treatment option for patients with chronic lymphocytic leukaemia
21 November 2019 - Today, as part of Project Orbis, a collaboration with the Australian Therapeutic Goods Administration and Health Canada, ...
Posted by Michael Wonder on 25 Sep 2019
TGA approves drug to fight ovarian cancer
26 September 2019 - Some women diagnosed with ovarian cancer could have their survival rates significantly increased after the Therapeutic ...
Posted by Michael Wonder on 17 Sep 2019
Provisional approval of lenvatinib in combination with pembrolizumab for the treatment of advanced endometrial carcinoma
18 September 2019 - The Therapeutic Goods Administration has provisionally approved the use of lenvatinib (Lenvima) in combination with pembrolizumab ...
Posted by Michael Wonder on 06 Aug 2019
Alimera announces Iluvien regulatory approval in Australia for the treatment of diabetic macular oedema
5 August 2019 - Specialised Therapeutics, an Australian biopharmaceutical company and Alimera’s distribution partner, to next seek national reimbursement. ...
Posted by Michael Wonder on 22 Jul 2019
'I owe it everything': cancer drug approval win for rare cancers
23 July 2019 - Paul Hazelwood was told there was nothing else doctors could do to treat his rare terminal ...